Literature DB >> 25316867

Progress toward laboratory containment of poliovirus after polio eradication.

Christopher Wolff1, Sigrun Roesel2, Galina Lipskaya3, Mauricio Landaverde4, Asghar Humayun5, Nalini Withana6, Nalini Ramamurty7, Oyewale Tomori8, Samuel Oumo Okiror9, Mbaye Salla10, Walter Dowdle11.   

Abstract

BACKGROUND: The first steps (phase 1) toward laboratory containment of poliovirus after eradication are a national survey of biomedical facilities and a global inventory of such facilities retaining wild poliovirus (WPV) infectious and potentially infectious materials.
METHODS: We reviewed published reports on national laboratory surveys and inventories of WPV materials from each of the 3 polio-free World Health Organization (WHO) regions (the European Region, completed in 2006; the Western Pacific Region, completed in 2008; and the Region of the Americas, completed in 2010), as well as reports on progress in polio-free countries of the remaining 3 regions (the African Region, the Eastern Mediterranean Region, and the WHO South-East Asia Region).
RESULTS: Containment phase 1 activities are complete in 154 of 194 WHO Member States (79%), including all countries and areas of the polio-free regions and most polio-free countries in the remaining 3 regions. A reported 227 209 biomedical facilities were surveyed, with 532 facilities in 45 countries identified as retaining WPV-associated infectious or potentially infectious materials.
CONCLUSIONS: Completion of containment phase 1 global activities is achievable within the time frame set by the Polio Eradication and Endgame Strategic Plan 2013-2018.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  OPV cessation; laboratory containment; polio endgame; polio eradication; poliovirus

Mesh:

Year:  2014        PMID: 25316867     DOI: 10.1093/infdis/jit821

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Towards an effective poliovirus laboratory containment strategy in Nigeria.

Authors:  Johnson Muluh Ticha; Kolawole Olatunji Matthew; Abdullahi Walla Hamisu; Braka Fiona; Pascal Mkanda; Peter Nsubuga; Eberto Tesfaye; Kehinde Craig; Etsano Andrew; Obi Emelife; Faisal Shuaib; Akinkugbe Folasade; Johnson Adeniji; Usman Adamu; Mohammed Dallatu; Geoffrey Oyeyinka; Holly Brown; Nwakasik Nnamah; Joseph Okwori; Chukwuike Chinedu; Ibikunle Anibijuwon; Adewumi Olubusuyi; Donbraye Emmanuel; Murtala Bagana; Marycelin Baba; Gumede Nicksy; Richard Banda; Sisay G Tegegne; Ajiboye Oyetunji; Ousmane Diop; O Tomori; Rui G Vaz
Journal:  BMC Public Health       Date:  2018-12-13       Impact factor: 3.295

2.  Distribution pattern of poliovirus potentially infectious materials in the phase 1b medical laboratories containment in conformity with the global action plan III.

Authors:  Bassey Enya Bassey; Fiona Braka; Faisal Shuaib; Richard Banda; Sisay Gashu Tegegne; Johnson Muluh Ticha; Walla Hamisu Abdullalhi; Olatunji Mathew Kolawole; Yusuf Kabir
Journal:  BMC Public Health       Date:  2018-12-13       Impact factor: 3.295

3.  Surveillance optimisation to detect poliovirus in the pre-eradication era: a modelling study of England and Wales.

Authors:  K M O'Reilly; N C Grassly; D J Allen; M Bannister-Tyrrell; A Cameron; A I Carrion Martin; M Ramsay; R Pebody; M Zambon
Journal:  Epidemiol Infect       Date:  2020-05-13       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.